Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction.
Insulin-resistant states are characterized by hypertriglyceridemia, predominantly because of overproduction of hepatic very low density lipoprotein particles. The additional contribution of intestinal lipoprotein overproduction to the dyslipidemia of insulin-resistant states has not been previously appreciated. Here, we have investigated intestinal lipoprotein production in a fructose-fed hamster model of insulin resistance previously documented to have whole body and hepatic insulin resistance, and hepatic very low density lipoprotein overproduction. Chronic fructose feeding for 3 weeks induced significant oversecretion of apolipoprotein B48 (apoB48)-containing lipoproteins in the fasting state and during steady state fat feeding, based on (a) in vivo Triton WR1339 studies of apoB48 production as well as (b) ex vivo pulse-chase labeling of intestinal enterocytes from fasted and fed hamsters. ApoB48 particle overproduction was accompanied by increased intracellular apoB48 stability, enhanced lipid synthesis, higher abundance of microsomal triglyceride transfer protein mass, and a significant shift toward the secretion of larger chylomicron-like particles. ApoB48 particle overproduction was not observed with short-term fructose feeding or in vitro incubation of enterocytes with fructose. Secretion of intestinal apoB48 and triglyceride was closely linked to intestinal enterocyte de novo lipogenesis, which was up-regulated in fructose-fed hamsters. Inhibition of fatty acid synthesis by cerulenin, a fatty acid synthase inhibitor, resulted in a dose-dependent decrease in intestinal apoB48 secretion. Overall, these findings further suggest that intestinal overproduction of apoB48 lipoproteins should also be considered as a major contributor to the fasting and postprandial dyslipidemia observed in response to chronic fructose feeding and development of an insulin-resistant state.
Haidari
Mehran
M
Department of Laboratory Medicine and Pathobiology, Hospital for Sick Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada.
Leung
Nathalie
N
Mahbub
Farhana
F
Uffelman
Kristine D
KD
Kohen-Avramoglu
Rita
R
Lewis
Gary F
GF
Adeli
Khosrow
K
D000085:Acetates / Q000378:metabolism; D000818:Animals; D053283:Apolipoprotein B-48; D001055:Apolipoproteins B / Q000096:biosynthesis; D002478:Cells, Cultured; D006224:Cricetinae; D004847:Epithelial Cells / Q000166:cytology / Q000502:physiology; D005215:Fasting / Q000502:physiology*; D005632:Fructose / Q000494:pharmacology*; D022781:Hepatocytes / Q000378:metabolism*; D007333:Insulin Resistance / Q000502:physiology*; D007413:Intestinal Mucosa / Q000378:metabolism*; D007421:Intestine, Small; D007700:Kinetics; D008074:Lipoproteins / Q000096:biosynthesis*; D008297:Male; D008647:Mesocricetus; D023421:Models, Animal; D011092:Polyethylene Glycols / Q000494:pharmacology; D019518:Postprandial Period / Q000502:physiology*; D013501:Surface-Active Agents / Q000494:pharmacology; D013997:Time Factors; D014280:Triglycerides / Q000096:biosynthesis*; D014316:Tritium
D000085:Acetates; D053283:Apolipoprotein B-48; D001055:Apolipoproteins B; D008074:Lipoproteins; D013501:Surface-Active Agents; D014280:Triglycerides; D014316:Tritium; D005632:Fructose; D011092:Polyethylene Glycols; C016811:tyloxapol